Bibliography
- Kaik G. Combined administration of ipratropium bromide (sch 1000) and fenoterol in patients with chronic obstructive airway disease. Wien Klin Wochenschr 1975;87:653-6
- Chrischilles E, Gilden D, Kubisiak J, et al. Delivery of ipratropium and albuterol combination therapy for chronic obstructive pulmonary disease: effectiveness of a two-in-one inhaler versus separate inhalers. Am J Manag Care 2002;8:902-11
- Friedman M, Serby CW, Menjoge SS, et al. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest 1999;115(3):635-41
- Fitzgerald MF, Fox JC. Emerging trends in the therapy of COPD: novel anti-inflammatory agents in clinical development. Drug Discov Today 2007;12:479-86
- Norman P. Dual-acting β2 agonists/muscarinic antagonists. Expert Opin Ther Patents 2006;16:1327-31
- Theravance, Inc. Crystalline form of a biphenyl compound. WO2006023454; 2006
- Glaxo Group Ltd. Succinic acid salt of biphenyl-2-ylcarbamic acid 1-[2- (2-chloro-4-{[(R)-2-hydroxy-2- (8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl) ethylaminoimethyl]}-5-methoxyphenylcarbamoyl) ethyl] piperidin-4-yl ester and its use for the treatment of pulmonary disorders. WO2007090859; 2007
- Theravance, Inc. Crystalline forms of a dimethylphenyl compound. WO2007127297; 2007
- Argenta Discovery Press Release 31 January 2007. Available from: http://www.forbion.com/downloads/AstraZeneca_sign_COPD_31_01_2007.pdf
- Argenta Discovery Ltd. Azole and thiazole derivatives and their use. WO2007017669; 2007
- Argenta Discovery Ltd. Bicyclo[2.2.]hept-7-ylamine derivatives and their uses. WO2007017670; 2007
- Argenta Discovery Ltd. Nitrogen containing heterocyclic compounds useful as M3-receptor modulators. WO2008023157; 2008
- Pfizer Ltd. Amine derivatives. WO2007107828; 2007
- Pfizer, Inc. Pfizer Pipeline 28 February 2008. Available from: http://media.pfizer.com/files/research/pipeline/2008_0228/pipeline_2008_0228.pdf
- Pfizer Ltd. Compounds having beta-agonist activity. WO2005092841; 2005